Astrazeneca (AZN)

 

Latest News

Faslodex CHMP positive opinion in 1L breast cancer

RNS Number: 0368J AstraZeneca PLC 23 June 2017 23 June 2017 12:45BST FASLODEX (FULVESTRANT) RECEIVES POSITIVE CHMP OPINION FOR USE IN 1st-LINE HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER CHMP positive recommendation is based on Phase III data demonstrating a 20% reduction in risk of disease worsening or d...

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC

Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price tar...

FTSE falls on sharp drop in oil prices

Oil prices plummeted by at least 3% after the Energy Information Administration suggested supply outstripped demand a...

Rally in banks and miners support FTSE

The FTSE 100 defied subdued trading in the US and Asia ahead of the UK general election on Thursday thanks to a rally i...

All News

DateHeadlineSource
23-06-17Faslodex CHMP positive opinion in 1L breast cancerRNS
16-06-17Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
07-06-17FTSE falls on sharp drop in oil prices StockMarketWire
07-06-17Rally in banks and miners support FTSEStockMarketWire
07-06-17AZ deal with Grunenthal over migraine treatment StockMarketWire
07-06-17AZ agreement with Gr?nenthal for rights to ZomigRNS
06-06-17ASTRAZENECA PRICES A $2BN BOND ISSUERNS
05-06-17Oil prices fall on diplomatic row with Qatar StockMarketWire
05-06-17Airlines and miners weigh on index after London attackStockMarketWire
05-06-17AZ reports positive results for breast cancer drug StockMarketWire
05-06-17LYNPARZA: SIGNIFICANT PFS IN BRCAm BREAST CANCERRNS
02-06-1712 AIM shares in the 1,000% clubInteractive Investor
01-06-17BP boosts FTSE 100StockMarketWire
01-06-17Block listing Interim ReviewRNS
01-06-17Total Voting RightsRNS
31-05-17Directorate ChangeRNS
26-05-17Broker Forecast - Investec issues a broker note on AstraZeneca PLCStockMarketWire
24-05-17Director/PDMR ShareholdingRNS
23-05-17Bydureon EXSCEL trial meets T2D safety objectiveRNS
22-05-17FTSE rises on telecoms and minersStockMarketWire
22-05-17FTSE opens higher on miners, comm. propertyStockMarketWire
22-05-17AZ agreement with Recordati for SelokenStockMarketWire
22-05-17AZ AGREEMENT WITH RECORDATI FOR SELOKEN IN EUROPERNS
18-05-17Fund manager's favourite small-cap pharma shares Interactive Investor
18-05-17Woodford Income Focus versus Equity Income: What's the difference?Interactive Investor
17-05-17Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLCStockMarketWire
17-05-17Broker Forecast - Berenberg issues a broker note on AstraZeneca PLCStockMarketWire
16-05-17Director Deals - AstraZeneca PLC (AZN)StockMarketWire
16-05-17Broker Forecast - Shore Capital issues a broker note on AstraZeneca PLCStockMarketWire
16-05-17Director/PDMR ShareholdingRNS
15-05-17FTSE 100 smashes record againInteractive Investor
15-05-17Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLCStockMarketWire
12-05-17Weaker sterling and telecoms boost FTSEStockMarketWire
12-05-17Why Neil Woodford just bought Lloyds Bank sharesInteractive Investor
12-05-17Stronger pharma stocks offset downbeat miners and banksStockMarketWire
12-05-17Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
12-05-17FTSE helped higher in early deals by mixed bagStockMarketWire
12-05-17AZ reports positive results for lung cancer drug StockMarketWire
12-05-17IMFINZI SIGNIFICANT PFS - UNRESECTABLE LUNG CANCERRNS
10-05-17AZ asthma drug fails to meet endpoint in pivotal trial StockMarketWire

RSS feeds

  • Editorial news feed for LSE:AZN Editorial
  • Regulatory news feed for LSE:AZN Regulatory